Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sinzinger

Showing results (361-370 of 672) with videos related to

Pageof 68
Sort By:
Basic Research in Cardiology|November 1, 1988
Beneficial effect of PGI2 on circulating endothelial cellsH Sinzinger, F Rauscha, P Fitscha, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 4, 2001
6-oxo-PGF(1 alpha)and 8-epi-PGF(2 alpha)in the arterial wall layers of various species: a comparison between intact and atherosclerotic areasA Oguogho, H Kritz, O Wagner, et al.
Nuclear Medicine Communications|June 14, 2001
Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell linesM Rodrigues, W Kalinowska, C Zielinski, et al.
Zeitschrift Fur Kardiologie|August 1, 1982
[Molsidomine, a coronary drug with platelet-aggregating inhibitory activity]K Silberbauer, J Slany, H Sinzinger, et al.
Lancet (London, England)|December 9, 1978
Human rectal mucosa generates prostacyclinH Sinzinger, K Silberbauer, M Winter, et al.
Anatomischer Anzeiger|January 1, 1984
[Age and sex dependence of the diameter of the lumen of the ascending, thoracic and abdominal aorta]E Jäger, W Firbas, K Widhalm, et al.
Radiologia Diagnostica|January 1, 1980
[Early recognition of rejection reactions using 111indium-oxine-labelled thrombocytes]H Kolbe, H Sinzinger, P Angelberger, et al.
American Journal of Obstetrics and Gynecology|December 1, 1982
Reduced umbilical artery prostacyclin formation in complicated pregnanciesC Dadak, A Kefalides, H Sinzinger, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Vascular wall-rather than platelet PGE1-pretreatment in-vivo (but not in-vitro) decreases thrombogenicityG Karanikas, S Granegger, H Schima, et al.
Atherosclerosis|August 1, 1981
Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiographyK Silberbauer, G Schernthaner, H Sinzinger, et al.
Pageof 68

Showing results (361-370 of 672) with videos related to

Sort By:
Pageof 68
Basic Research in Cardiology|November 1, 1988
Beneficial effect of PGI2 on circulating endothelial cellsH Sinzinger, F Rauscha, P Fitscha, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 4, 2001
6-oxo-PGF(1 alpha)and 8-epi-PGF(2 alpha)in the arterial wall layers of various species: a comparison between intact and atherosclerotic areasA Oguogho, H Kritz, O Wagner, et al.
Nuclear Medicine Communications|June 14, 2001
Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell linesM Rodrigues, W Kalinowska, C Zielinski, et al.
Zeitschrift Fur Kardiologie|August 1, 1982
[Molsidomine, a coronary drug with platelet-aggregating inhibitory activity]K Silberbauer, J Slany, H Sinzinger, et al.
Lancet (London, England)|December 9, 1978
Human rectal mucosa generates prostacyclinH Sinzinger, K Silberbauer, M Winter, et al.
Anatomischer Anzeiger|January 1, 1984
[Age and sex dependence of the diameter of the lumen of the ascending, thoracic and abdominal aorta]E Jäger, W Firbas, K Widhalm, et al.
Radiologia Diagnostica|January 1, 1980
[Early recognition of rejection reactions using 111indium-oxine-labelled thrombocytes]H Kolbe, H Sinzinger, P Angelberger, et al.
American Journal of Obstetrics and Gynecology|December 1, 1982
Reduced umbilical artery prostacyclin formation in complicated pregnanciesC Dadak, A Kefalides, H Sinzinger, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Vascular wall-rather than platelet PGE1-pretreatment in-vivo (but not in-vitro) decreases thrombogenicityG Karanikas, S Granegger, H Schima, et al.
Atherosclerosis|August 1, 1981
Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiographyK Silberbauer, G Schernthaner, H Sinzinger, et al.
Pageof 68